Registration number:
HH PHARMA CONSULTANCY LTD
for the Period from 16 December 2022 to 31 December 2023
HH PHARMA CONSULTANCY LTD
Contents
Company Information |
|
Director's Report |
|
Balance Sheet |
|
Notes to the Unaudited Financial Statements |
HH PHARMA CONSULTANCY LTD
Company Information
Director |
Pauline Caddick |
Registered office |
|
Accountants |
|
HH PHARMA CONSULTANCY LTD
Director's Report for the Period from 16 December 2022 to 31 December 2023
The director presents her report and the financial statements for the period from 16 December 2022 to 31 December 2023.
This report has been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and in accordance with FRS 105 The Financial Reporting Standard applicable to the Micro-entities Regime.
Incorporation
The company was incorporated on
Director of the company
The director who held office during the period was as follows:
Small companies provision statement
This report has been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006.
Approved and authorised by the
......................................... |
HH PHARMA CONSULTANCY LTD
(Registration number: 14544629)
Balance Sheet as at 31 December 2023
2023 |
|
Fixed assets |
|
Current assets |
|
Prepayments and accrued income |
|
Creditors: Amounts falling due within one year |
( |
Net current assets |
|
|
|
Capital and reserves |
|
General information |
The company is a private company limited by share capital, incorporated in England and Wales.
The address of its registered office is:
These financial statements were authorised for issue by the
Basis of preparation
The financial statements have been prepared under the historical cost convention and in accordance with FRS 105 'The Financial Reporting Standard applicable to the Micro-entities Regime'.
Staff numbers |
The average number of persons employed by the company (including the director) during the period, was
For the financial period ending 31 December 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Director's responsibilities:
• |
|
• |
The director acknowledges her responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts. |
These financial statements have been prepared in accordance with the micro-entity provisions of the Companies Act 2006 and delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime. As permitted by section 444 (5A) of the Companies Act 2006, the director has not delivered to the registrar a copy of the Profit and Loss Account.
HH PHARMA CONSULTANCY LTD
(Registration number: 14544629)
Balance Sheet as at 31 December 2023 (continued)
Approved and authorised by the
......................................... |